Abraxis Oncology® is the proprietary pharmaceuticals division of Abraxis BioScience, LLC, an integrated global biopharmaceutical company. Abraxis Oncology® is dedicated to the discovery and development of novel cancer therapies that target tumor biological pathways. Our focus is to challenge current standards and develop next-generation therapies that revolutionize the treatment of cancer. Through innovative science and creative thinking, Abraxis Oncology® is redefining cancer therapy as we know it. It is our hope that the discovery of new technologies and new compounds will improve survival, as well as tolerability, across a range of tumor types.
